covid-19: clinical trials bounce back after significant disruption | dana-farber cancer institute
Published 2 years ago • 144 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
2:09
covid-19 and cancer clinical trials: dana-farber cancer institute case study
-
50:49
cancer and covid 19 clinical trials webinar
-
1:38
cancer and covid-19: high risk patients | dana-farber cancer institute
-
1:14
covid-19 and genitourinary cancer: pandemic's impact | dana-farber cancer institute
-
1:35
covid-19 and cancer: breakthrough infections
-
2:15
dana-farber cancer institute administers covid-19 vaccinations
-
43:54
how dana-farber is meeting the challenges posed by covid-19
-
37:17
lymphoma clinical trials and new treatment options | dana-farber cancer institute
-
1:16
improving access to blood cancer clinical trials | dana-farber cancer institute
-
59:19
childhood cancer in the time of covid: how dana-farber continues to lead the way
-
23:32
the latest in clinical trials for brain tumor patients | dana-farber cancer institute
-
1:25
asco23: patrick wen, md | dana-farber cancer institute
-
1:33
covid booster and cancer | dana-farber cancer institute
-
0:31
ovarian cancer patient has extraordinary response to clinical trial treatment
-
2:14
prostate cancer research: launching a study during the covid-19 pandemic
-
3:37
aml clinical trials | when to consider this treatment option
-
32:15
clinical trials for brain tumor patients | dana-farber cancer institute
-
58:29
clinical trials 101 | 2022-2023 embrace mbc virtual forum series